Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1197)
  3. Review (75)
  4. Research Letter (48)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2969)
  2. Department of Medicine (2969)
  3. Hematologic Malignancies, Division of (2846)
  4. Survivorship Research (1387)
  5. GSK Faculty (931)
  6. CTCR Scholars (872)

More Groups

People
  1. Sergio Giralt (1067)
  2. Miguel-Angel Perales (942)
  3. Sean Devlin (469)
  4. Ann Jakubowski (458)
  5. Gunjan Shah (446)
  6. Heather Landau (435)

More People

Years
  1. 2025 (66)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (94)

More Publications

Publishers
  1. American Society of Hematology (988)
  2. Elsevier Inc. (766)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2969)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Consolidation patterns and associated outcomes for a large cohort of primary CNS lymphoma patients
    Meeting Abstract

    Imber, B.; Tringale, K.; Scordo, M.; Yahalom, J.; Grommes, C.
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save
  • Primary overall survival (OS) analysis of the phase 3 randomized ZUMA-7 study of axicabtagene ciloleucel (axi-cel) versus standard-of-care (SOC) therapy in relapsed/refractory large B-cell lymphoma (R/R LBCL)
    Meeting Abstract

    Dreger, P.; Westin, J.; Oluwole, O.; Kersten, M. J.; Miklos, D.; Perales, M. A.; Ghobadi, A.; Rapoport, A.; Sureda, A.; Jacobson, C.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Subgroup analyses of primary refractory vs early relapsed large B-cell lymphoma (LBCL) from the TRANSFORM study of lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) as second-line (2L) therapy
    Meeting Abstract

    Glass, B.; Nastoupil, L.; Kamdar, M.; Chavez, J. C.; Ghesquieres, H.; Ghosh, M.; Holmes, H.; López-Guillermo, A.; Martínez-López, J.; Novak, U.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Idecabtagene vicleucel (Ide-cel) versus standard regimens in patients (pts) with triple-class-exposed (TCE) relapsed and refractory multiple myeloma (RRMM): KarMMa-3 a phase 3 randomized controlled trial (RCT)
    Meeting Abstract

    Scheid, C.; Otero, P. R.; Ailawadhi, S.; Arnulf, B.; Patel, K.; Cavo, M.; Nooka, A. K.; Manier, S.; Callander, N.; Costa, L. J.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Patient reported outcomes in triple class exposed, relapsed/refractory multiple myeloma (TCE RRMM) patients in KarMMa 3 trial (Phase 3 RCT): Idecabtagene Vicleucel (ide-cel) versus standard regimens
    Meeting Abstract

    Einsele, H.; Delforge, M.; Patel, K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T.; Arnulf, B.; Cavo, M.; more...
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Salvage radiotherapy as a bridge for relapsed secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K. R.; Hajj, C.; Hubbeling, H. G.; Sarkar, R. R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Pike, L. R. G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Optimized double-unit cord blood transplantation mitigates transplant related mortality resulting in high progression-free survival in adults with hematologic malignancies
    Meeting Abstract

    Politikos, I.; Devlin, S.; Chinapen, S.; Quach, S.; Dahi, P.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; Ponce, D.; Tamari, R.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Initial first-in-human results: CD33-deleted hematopoietic stem and progenitor cells display normal engraftment after hematopoietic cell transplant (HCT) and tolerate post-hct gemtuzumab ozogamicin (GO) without cytopenias
    Meeting Abstract

    Tomlinson, B.; Suh, H. C.; Koura, D.; Koehne, G.; Cho, C.; Bambace, N. M.; Bernard, L.; Shah, N.; Walter, R. B.; DiPersio, J. F.; more...
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation
    Meeting Abstract

    Tejura, B.; Kosuri, S.; Khera, N.; DeFilipp, M. Z.; Lombardo, M. J.; Ford, C.; Peled, J. U.; van den Brink, M. R. M.; von Moltke, L.; Ponce, D. M.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save
  • Study design and rationale of stargaze - A phase 2 clinical trial evaluating apraglutide in patients with steroid-refractory gastrointestinal (GI) acute graft-versus-host disease (AGvHD)
    Meeting Abstract

    Zeiser, R.; Perales, M. A.; Adelman, H.; Bolognani, F.; Hockenbery, D.
    Bone Marrow Transplantation (2023)

    Fulltext@MSK | Save